[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346602-105":59,"doc-detail-346602-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","otud4-deubiquitination-stabilizes-egfr-and-activates-the-pi3kakt-pathway-to-promote-the-invasiveness-of-triple-negative-breast-cancer","OTUD4 deubiquitination stabilizes EGFR and activates the PI3K/AKT pathway to promote the invasiveness of triple-negative breast cancer","","OTUD4 functions as a deubiquitinating enzyme whose oncogenic role in triple-negative breast cancer remains unresolved. This study combines bioinformatics with experimental validation, showing OTUD4 overexpression in TNBC and an association with poor prognosis. OTUD4 downregulation reduces TNBC invasiveness, while mechanistic assays indicate EGFR stabilization and PI3K/AKT pathway activation. The effects involve OTUD4–EGFR interaction, K48-linked polyubiquitin chain cleavage, and NRP1-mediated recruitment for deubiquitination. Findings clarify EGFR signaling in TNBC and suggest therapeutic targets.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/otud4-deubiquitination-stabilizes-egfr-and-activates-the-pi3kakt-pathway-to-promote-the-invasiveness-of-triple-negative-breast-cancer/346602/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/otud4-deubiquitination-stabilizes-egfr-and-activates-the-pi3kakt-pathway-to-promote-the-invasiveness-of-triple-negative-breast-cancer/346602.png","ImageObject",300,407,{"name":92,"@type":93},"Ava Thompson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-13","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main finding about OTUD4 in triple-negative breast cancer?","Question",{"text":112,"@type":113},"OTUD4 is overexpressed in TNBC and correlates with poor prognosis. OTUD4 downregulation reduces TNBC invasiveness.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does OTUD4 promote TNBC progression mechanistically?",{"text":117,"@type":113},"OTUD4 stabilizes EGFR expression and activates the PI3K/AKT pathway. This occurs via direct OTUD4–EGFR interaction, K48-linked polyubiquitin chain cleavage, and NRP1-mediated recruitment.",{"name":119,"@type":110,"acceptedAnswer":120},"Which experimental approaches were used to support the conclusions?",{"text":121,"@type":113},"The study integrates bioinformatics analysis of OTUD4 expression with in vitro and in vivo functional analyses. It also examines clinical samples and cell culture conditions, and uses TCGA-BRCA phenotype data and UALCAN for expression assessment.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},346602,1790186607,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1649267921044,"https://us-avatar.wpscdn.com/avatar/1800007509477c92dfb?_k=1786009248482753345","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nOTUD4 deubiquitination stabilizes EGFR and activates the PI3K/ AKT pathway to promote the invasiveness of triple-negative breast cancer  \nYu Ren 1,2,7, Fulin Zhou2,3,7, Zhihua Tan2,4,7, Senguo Yang1,2, Shaolin Zhang2,5, Yonglin Zhang 1,2, Yumei Fu1, Mai Zhang6 and Shu Liu 1,2 ✉  \n© The Author(s) 2026  \n\n|  |  |  |  |  |\n| --- | --- | --- | --- | --- |\n|  | The deubiquitinating enzyme OTUD4 functions as an oncogene in various cancers, but its role in triple-negative breast cancer (TNBC) remains unclear. Through bioinformatics analysis and experimental validation, we demonstrate that OTUD4 is overexpressed in TNBC and correlates with poor prognosis. OTUD4 downregulation reduces TNBC invasiveness, highlighting its oncogenic role. Mechanistically, OTUD4 promotes TNBC progression by stabilizing EGFR expression and activating the PI3K/AKT pathway. This stabilization occurs through two mechanisms: direct interaction between OTUD4 (568–1114aa) and EGFR (958-1210aa) and OTUD4-mediated cleavage of K48-linked polyubiquitin chains. Additionally, OTUD4 is recruited by NRP1 to deubiquitinate and further stabilize EGFR. These ﬁndings enhance our understanding of EGFR signaling in TNBC and may inform novel therapeutic strategies. |  |  |  |\n|  |  |  |  |  |\n|  |  |  |  |  |\n|  |  |  |  |  |\n|  |  |  |  |  |\n|  |  |  |  |  |\n|  |  |  |  |  |\n|  | Cell Death and Disease (2026)17:245; [https://doi.org/10.1038/s41419-026-08482-x](https://doi.org/10.1038/s41419-026-08482-x) |  |  |  |\n|  |  |  |  |  |\n\nINTRODUCTION  \nTriple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer (BC), accounting for approximately 25% of cases, and is associated with the poorest prognosis. Treatment options remain limited, relying primarily on conventional chemotherapy and surgery [1–3] . Notably, TNBC frequently exhibits overexpression of epidermal growth factor receptor (EGFR), which is linked to adverse clinical outcomes [4–7] . EGFR promotes tumor progression by regulating cell proliferation, metastasis, apoptosis inhibition, and drug resistance through activation of downstream signaling pathways, particularly PI3K/ AKT/mTOR [8–10] .  \nDeubiquitinases (DUBs), a family of approximately 100 enzymes [11], counteract ubiquitin ligases (UBs) by removing ubiquitin chains from target proteins [12], thereby preventing proteasomal degradation and maintaining protein functions [13] . Under normal physiological conditions, cellular homeostasis is maintained through a dynamic balance between ubiquitination and deubiquitination. However, dysregulation of certain DUBs contributes to tumorigenesis [14] .  \nOTU domain-containing 4 (OTUD4), a deubiquitinating enzyme of the ovarian tumor protease domain (OTUD) family [15], has been implicated in cancer progression. OTUD4 enhances tumor metastasis by collaborating with IRTKS to promote SETDB1-mediated H3K9 trimethylation, leading to E-cadherin suppression [16] . Additionally, OTUD4 stabilizes CDK1 by removing K11-, K29-, and K33-linked multiubiquitination and reduces K6- and K27-linked ubiquitination of FGFR1, thereby activating the MAPK  \npathway and promoting glioblastoma progression [17] . By stabilizing Snail1, OTUD4 regulates melanoma metastasis and chemoresistance [18] . Furthermore, in TNBC, OTUD4 stabilizes CD73 by counteracting TRIM21-mediated ubiquitination, contributing to immune evasion [19] .  \nIn this study, we demonstrate that OTUD4 is highly expressed in TNBC and correlates with poor prognosis. Functional analyses reveal that OTUD4 enhances TNBC aggressiveness both in vitro and in vivo through the EGFR-mediated PI3K/AKT pathway. Mechanistically, OTUD4 (568–1114aa) interacts with EGFR (1–600aa) and stabilizes EGFR independently and via NRP1 recruitment for deubiquitination. These ﬁndings provide new insights into TNBC pathogenesis and potential therapeutic targets.  \nMATERIALS AND METHODS Cell culture  \nThe normal breast and BC cel","cbCaiiruNB0ZgEY8","https://ap.wps.com/l/cbCaiiruNB0ZgEY8","pdf",8081764,13,"English","# Introduction\n## Materials and Methods\n### Cell culture\n### Clinical samples\n### Bioinformatics analysis","[{\"question\":\"What is the main finding about OTUD4 in triple-negative breast cancer?\",\"answer\":\"OTUD4 is overexpressed in TNBC and correlates with poor prognosis. OTUD4 downregulation reduces TNBC invasiveness.\"},{\"question\":\"How does OTUD4 promote TNBC progression mechanistically?\",\"answer\":\"OTUD4 stabilizes EGFR expression and activates the PI3K/AKT pathway. This occurs via direct OTUD4–EGFR interaction, K48-linked polyubiquitin chain cleavage, and NRP1-mediated recruitment.\"},{\"question\":\"Which experimental approaches were used to support the conclusions?\",\"answer\":\"The study integrates bioinformatics analysis of OTUD4 expression with in vitro and in vivo functional analyses. It also examines clinical samples and cell culture conditions, and uses TCGA-BRCA phenotype data and UALCAN for expression assessment.\"}]","OTUD4 deubiquitination stabilizes EGFR and activates the PI3K/AKT pathway to promote the invasiveness of triple-negative breast cancer | PDF",1790062100,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a6cf412b3dbe0aa23da2490b8920c6e5.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d2158ac0914bde731bd0d4c879726a12.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/addc567bdf8f38281178765d0e16f4be.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b3ccaf5fa9ea2ccfced332d4862ff27f.webp",980,1301]